05:15 PM EDT, 04/18/2024 (MT Newswires) -- Michael Secora, Chief Financial Officer, on April 16, 2024, sold 48,124 shares in Recursion Pharmaceuticals ( RXRX ) for $367,007. Following the Form 4 filing with the SEC, Secora has control over a total of 1,231,055 shares of the company, with 1,231,055 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1601830/000160183024000036/xslF345X03/wk-form4_1713474733.xml